|
|
|
Volumn 15, Issue 6, 2007, Pages 450-455
|
|
An experimental study on the reverse mechanism of PPAR-gamma agonist rosiglitazone in rats with non-alcoholic steatohepatitis
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2,4 THIAZOLIDINEDIONE DERIVATIVE;
ANTIDIABETIC AGENT;
CYCLOOXYGENASE 2;
I KAPPA B KINASE;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;
PTGS2 PROTEIN, RAT;
ROSIGLITAZONE;
TUMOR NECROSIS FACTOR ALPHA;
ANIMAL;
ARTICLE;
DRUG POTENTIATION;
FATTY LIVER;
MALE;
METABOLISM;
PATHOLOGY;
RAT;
SIGNAL TRANSDUCTION;
WISTAR RAT;
ANIMALS;
CYCLOOXYGENASE 2;
FATTY LIVER;
HYPOGLYCEMIC AGENTS;
I-KAPPA B KINASE;
MALE;
NF-KAPPA B;
PPAR GAMMA;
RATS;
RATS, WISTAR;
SIGNAL TRANSDUCTION;
THIAZOLIDINEDIONES;
TUMOR NECROSIS FACTOR-ALPHA;
|
|
EID: 39849091923
PISSN: 10073418
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (4)
|
|
References (0)
|
